About
Early Cancer Detection
Areas of Focus
Categories
DiagnosticsMidwest
Team (8)
Clinical Trials (27)
View allTotal Trials
27
As Lead Sponsor
4
As Collaborator
23
Total Enrollment
74,401
By Phase
NA: 14PHASE4: 2PHASE2: 3PHASE3: 2
By Status
COMPLETED: 17RECRUITING: 3TERMINATED: 3NOT_YET_RECRUITING: 1UNKNOWN: 1ENROLLING_BY_INVITATION: 1WITHDRAWN: 1
Clinical Trials Pipeline27 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06655337Collaborator
"Efficiency of the Medidux Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)"
NARecruiting
417 participants
Started: Sep 28, 2025 · Completed: Mar 28, 2027
NCT06790771Collaborator
Effect of Supplement on Appetite and GLP-1
NANot yet recruiting
25 participants
Started: Jan 15, 2025 · Completed: Dec 15, 2025
NCT05763602Collaborator
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
PHASE4Recruiting
2,000 participants
Started: Sep 15, 2022 · Completed: Feb 15, 2026
NCT05425550Lead Sponsor
Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer.
NATerminated
196 participants
Started: Aug 29, 2022 · Completed: Jun 5, 2025
NCT05354973Collaborator
ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy
N/ARecruiting
11 participants
Started: Mar 21, 2022 · Completed: Apr 30, 2025
Locations (1)
Headquarters
Evanston, IL, United States
Map
Loading map...